Related Experiment Videos
Genetic factors in allograft unresponsiveness
Survey of Immunologic Research
|January 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
STUDIES ON THE PROBLEM OF PRESERVATION OF MYELIN SHEATH ULTRASTRUCTURE: EVALUATION OF FIXATION, DEHYDRATION, AND EMBEDDING TECHNIQUES.
The Journal of biophysical and biochemical cytology·2009
Short communication: progression of Johne's disease curtailed by a probiotic.
Journal of dairy science·2009
Bacteremia with esophageal dilation.
Gastrointestinal endoscopy·1998
Rejection of rat skin xenografts by either murine CD4 or CD8 T cells.
Transplantation·1994
Role of the immune system in the etiology of rheumatic fever.
Survey of immunologic research·1985
Recognition of an Igh-linked histocompatibility antigen, H-40, on B-cell tumors by cytotoxic T lymphocytes.
Survey of immunologic research·1985
Macrophages in the thymus.
Survey of immunologic research·1985
Modulation of immune response in aged humans through different administration modes of thymopentin.
Survey of immunologic research·1985
Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
Survey of immunologic research·1985
Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
Survey of immunologic research·1985
Lung biopsy strategies for childhood interstitial lung disease: Indications and techniques.
The Journal of international medical research·2026
"I know how important it is": A qualitative analysis of participants' experiences in a vaccine safety study.
Human vaccines & immunotherapeutics·2026
Evolution and Mechanistic Insights of Immunometabolism in Metabolic Diseases and Infections.
Scandinavian journal of immunology·2026
Early longitudinal proteomic changes during sirolimus therapy in tocilizumab-refractory idiopathic multicentric Castleman disease.
Rheumatology (Oxford, England)·2026
Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial.
Cancer chemotherapy and pharmacology·2026